![](https://pharmashots.com/public/default-image/default-730x400.png )
Johnson & Johnson Collaborates with the Government of Canada to Supply its Ad26.COV2.S for COVID-19
Shots:
- Janssen signs an agreement in principle with the Government of Canada to supply its COVID-19 vaccine- ensuring broad Canadian access to Ad26.COV2.S- following Health Canada’s approval
- In addition- a final agreement will be determined in due course under which the Government of Canada would purchase ~38M doses of Janssen’s vaccine candidate on a not-for-profit basis for emergency pandemic use
- The vaccine is currently being evaluated in P-I/IIa study in the US and Belgium while the company is planning for conducting P-III study following interim data of the P-I/IIa studies and approval of regulators
Ref: J&J | Image: TrialSite News
Click here to read the full press release
![](https://pharmashots.com/public/public/images/Senior-2023-08-17-64ddc3af74ec4.png)
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com